List of abbreviations: ALS: amyotrophic lateral sclerosis; ATG4B: autophagy related 4B cysteine peptidase; AUC: area under the curve; FTLD: frontotemporal lobar degeneration; iPSC: induced pluripotent stem cells; ROC: receiver operating characteristic; TARDBP: TAR DNA binding protein; RT-qPCR: quantitative RT-PCR A c c e p t e d M a n u s c r i p t 2 Abstract TARDBP (TAR DNA binding protein) is one of the components of neuronal aggregates in sporadic amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration. We have developed a simple quantitative method to evaluate TARDBP splicing function that was applied to spinal cord, brainstem, motor cortex, and occipital cortex in ALS (n=8) cases compared to age-and gendermatched control (n=17). Then, we quantified the abundance of a TARDBP-spliced cryptic exon present in ATG4B (autophagy related 4B cysteine peptidase) mRNA. Results of these analyses demonstrated that the loss of this TARDBP function in spinal cord, brainstem, motor cortex, and occipital cortex differentiated ALS from controls (area under the curve of receiver operating characteristic: 0.85). Significant correlations were also observed between cryptic exon levels, age, disease duration, and aberrant mRNA levels. To test if TARDBP function in splicing is relevant in ATG4B major function (autophagy) we downregulated TARDBP expression in human neural tissue and in HeLa cells, demonstrating that TARDBP is required for maintaining the expression of ATG4B. Further, ATG4B overexpression alone is sufficient to completely prevent the increase of SQSTM1 induced by TARDBP downregulation in human neural tissue cells and in cell lines. In conclusion, the present findings demonstrate abnormal alternative splicing of ATG4B transcripts in ALS neural tissue in agreement with TARDBP loss of function, leading to impaired autophagy.
Introduction
TARDBP (TAR DNA binding protein) is one of the components of neuronal aggregates in sporadic amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD).
Whether these aggregates are associated with TARDBP loss of function is not known. TARDBP is involved in the splicing of cryptic exons of selected mRNAs, such as of ATG4B (autophagy related 4B cysteine peptidase). Cryptic exons are considered splicing variants that may introduce frameshifts or stop codons, among other changes in the resulting mRNA. These aberrant mRNA have been demonstrated in motor cortex and middle temporal gyrus of ALS and FTLD patients [1] .
However, it was undetermined whether ALS target locations also presented cryptic exons. Further, whether these mRNA anomalies have any impact in translation of the corresponding proteins was unknown. In this brief report, we have developed a simple quantitative method to evaluate this TARDBP splicing function that was applied to samples of various central nervous system regions from ALS cases compared to age-and gender-matched control individuals. Further, we have characterized the effects of TARDBP loss in autophagy role of ATG4B.
Results and Discussion
RNA was extracted from 50-100 mg homogenized nervous tissue. We quantified the abundance of TARDBP-spliced cryptic exons present in ATG4B mRNAs with RT-qPCR. RT-qPCR results agree with the loss of TARDBP function in spinal cord, brainstem, motor cortex, and occipital cortex differentiating ALS from controls (area under the curve of ROC: 0.85, Figure 1A ).
Next, we observed that the abundance of cryptic exons in the ATGB transcript was mainly influenced by ALS status (p<0.005 for ALS status, p=0.69 for brain region and p=0.1 for interaction in 2-way ANOVA) ( Figure 1B ). Significant correlations were also observed between bulbar levels of cryptic exons and age ( Figure 1C ). Indeed, a more severe phenotype of the disease (i.e., shorter duration of disease after diagnosis) was associated with higher level of aberrant mRNAs ( Figure   1D ).
To demonstrate if TARDBP function is relevant in maintenance of ATG4B mRNA we downregulated TARDB in human nervous tissue cells. The results demonstrate that TARDBP A c c e p t e d M a n u s c r i p t 4 downregulation increased the amount of cryptic exons to up 20% of ATG4B mRNA ( Figure 1E) and causes a loss of 30% of ATG4B protein ( Figure 1F ). Nonsense-mediated decay of aberrant ATG4B mRNA may explain the hereby observed loss of ATG4B in human cells. The fact that this mRNA anomaly would target mainly motor neurons-a quantitatively minor cell population in these tissues-could account for the low percentage of mRNA affected and the apparent lack of quantitative differences of ATG4B protein in nervous tissue samples observed (data not shown).
Of note, sequence analyses suggest that loss of function of TARDBP on ATG4B cryptic exon introduces a premature stop codon leading to loss of residues 317-393 in the resulting protein.
Because these residues contain 2 phosphorylation sites required for ATG4B protein activity [10] , their loss induced by cryptic exon inclusion may result in defective autophagy.
To test if TARDBP function in splicing is relevant in ATG4B major cellular function (macroautophagy/autophagy) we downregulated TARDBP expression in HeLa cells. Results showed that TARDBP is required for maintaining the expression of ATG4B, as loss of TARDBP leads to an approximately 50% loss of ATG4B mRNA ( Figure 2A ) and protein ( Figure 2B ) in HeLa cells, in association with the presence of cryptic exons in 38% of ATG4B mRNA (Figure 2A ).
TARDBP is required to orchestrate a physiological autophagy response, as reinforced by the failure of TARDBP-deficient cells to increase ATG4B mRNA in cases of autophagy induction ( Figure 2A ); TARDBP-deficient HeLa cells also exhibited increased baseline levels of SQSTM1 ( Figure 2C ), a hallmark of autophagy disturbance [11] .
TARDBP deficiency might affect autophagy by other mechanisms, besides ATG4B downregulation, as it modifies the expression of transcripts of approximately 41 genes. However, ATG4B overexpression alone is sufficient to completely prevent the increase of SQSTM1 induced by TARDBP downregulation in HeLa and human neural tissue cells ( Figure 2D ). Noteworthy, ATG4B loss was not compensated by increased expression of other ATG4B homologs ( Figure S6 , ESM). Previous data have shown that SQSTM1 interacts with TARDBP aggregates in ALS [12] .
Together, the present data point to a novel mechanism implicating autophagy as a relevant factor in the pathogenesis of sporadic ALS, in addition to the involvement of autophagy pathway components in familial ALS including ALS2, OPTN, and SIGMAR1 [13].
A c c e p t e d M a n u s c r i p t 5 Besides ATG4B mRNA, other genes, such as GPSM2 (G protein signaling modulator 2) are also influenced by TARDBP dysfunction [1] . We also designed a RT-qPCR method for analysis of cryptic exon inclusion in its mRNA. The results confirm that abundance of cryptic exons in GPSM2 mRNA could also be useful for ALS diagnosis (area under the curve of ROC for GPSM2 aberrant mRNA: 0.89, Figure 3A ). Levels of GPSM2 aberrant mRNA are significantly influenced both by brain region and ALS type (bulbar ALS vs non-bulbar ALS; 2-way ANOVA: p<0.001 for interaction, p<0.0001 for disease status and p=0.0061 for brain region, Figure 3B ). Bulbar cases show higher levels of these mRNA in brain stem and occipital cortex, in comparison to spinal cord and frontal cortex, being opposite for non-bulbar cases. These results might be explained by spreading of the disease pathological traits (i.e., loss of TARDBP function) between adjacent anatomical locations, as indicated previously by neuroimaging techniques [14] . Furthermore, levels of cryptic exons in GPSM2 in frontal cortex correlate with those in spinal cord ( Figure 3C ).
Interestingly, and supporting the involvement of the loss of this TARDBP function as a common mechanism for appearance of both cryptic exons, levels of aberrant mRNA in GPSM2 correlate with those in ATG4B mRNAs in every tissue evaluated ( Figure 3D ).
In conclusion, we show the usefulness of tissue RT-qPCR in searching for cryptic exons as a rapid method to analyze TARDBP function, with potential implications in ALS diagnosis. We recognize that the usefulness for ALS diagnoses, based on this preliminary study, should be further substantiated by employing a larger number of individuals. This is evidenced by the shape of the ROC curve indicated above, showing the impact of a relative low number of specimens analyzed. Nonetheless, the present findings demonstrate abnormal alternative splicing of ATG4B transcripts in ALS neural tissue in agreement with TARDBP loss of function, leading to impaired autophagy.
Materials and Methods

Neuronal tissues
All samples were obtained from the Institute of Neuropathology and the University of Barcelona Brain Bank following the guidelines of the local ethics committees. Extensive A c c e p t e d M a n u s c r i p t 6 pathological studies were done for ALS diagnosis as previously described [2] . Samples from different anatomical locations were from 5 males and 3 females aged between 50 and 79 years affected with typical neurological and neuropathological characteristics of sporadic ALS. The postmortem delay between death and tissue processing was between 3 and 16 h. Age-and gendermatched controls with no clinical evidence of neurological disease and with a normal neuropathological study were processed in parallel (see Table S1 , Electronic Supplemental Material (ESM)).
Cell culture and treatments
HeLa cells were maintained in Dulbecco's Modified Eagle's Medium (Thermo Fisher Scientific, 11965), 10% FBS (Thermo Fisher Scientific, 10270), 100 U/ml penicillin-streptomycin (Thermo Fisher Scientific, 15140-122) at 37℃ and 5% CO 2 . Human neural tissue cells were obtained from Axol (Axol Biosciences, ax0018). Briefly, iPSC-Derived Neural Stem Cells derived from integration-free, induced pluripotent stem cells under fully defined neural induction condition were expanded and differentiated following System A of the manufacturer's protocol (version 5.0).
TARDBP knockdown cells were obtained by transducing cells with a TARDBP shRNA lentivirus (see below for further details). Cell media were changed the day after the transduction and the cells were cultured for further 96 h to allow TARDBP silencing.
For inducing autophagy by nutrient deprivation, cells were infected with scrambled or TARDBP shRNA as indicated above, and for the last 16 h after transduction the medium was replaced with complete fresh medium, as control, or HBSS (Thermo Fisher Scientific, 14025), for nutrient starvation.
shRNA design
Primer was designed against the sequence 5′-GACGATGGTGTGACTGCAAAC-3′ for human TARDBP and cloned in the pSUPER (Oligoengine, pSUPER). Then, an EcoRI-ClaI fragment containing the H1 promoter for RNA polymerase III and the shRNA sequence was cut from pSUPER and subcloned into the pLVTHM plasmid, a gift from Didier Trono (Addgene, 12247) [3] . shRNA vector, the plasmids psPAX2 (Addgene, 12260) and pMD2.G (Addgene, 12259) (both a gift from Dr. Trono) were transfected together using the polyethyleneimine transfection method 
RNA extraction, cDNA synthesis, conventional PCR and quantitative RT-PCR (RT-qPCR)
RNA was extracted from cells and tissue samples using TRI Reagent (Thermo Fisher Scientific, AM9738) following the manufacturer's instructions. RNA concentrations were measured using a NanoDrop ND-1000 (Thermo Fisher Scientific). One microgram of RNA was used for retrotranscription employing TaqMan Reverse Transcription Reagent using random hexamers (Thermo Fisher Scientific, N8080234).
Primers used to perform conventional PCR reaction were those previously described [1] , purchased from Roche Oligo synthesis service (Roche Diagnostics, Barcelona, Spain). For ATG4B
were as follows: initial denaturation at 98ºC for 30 sec, followed by 40 cycles of 98ºC for 30 sec, 63ºC for 12 sec and 72ºC for 30 sec. Gel analyses demonstrated the presence of potential ATG4B
and GPSM2 cryptic exons in samples from ALS patients ( Figure S1 , ESM), whose identity was ensured by Sanger sequencing (>99% sequence homology, E value ranging between 1 and 3e-40) as shown in Figure S2 and Figure S3 (ESM).
In order to quantify the level of cryptic exons we developed a RT-qPCR method. Briefly, A c c e p t e d M a n u s c r i p t M a n u s c r i p t M a n u s c r i p t 
RT
Genes Forward Reverse
Total ATG4B 5'-AACGCATTCATCGACAGGAAG-3' 5'-TTTGCGCTATCTGGTGAATGG-3'
Cryptic ATG4B 5'-CTGAGTGTGCATGGATGAGTG-3' 5'-TTGCTGGCACCAATCATTGAA-3' Figure S1 ). Figure S3 . Sequence of band corresponding to cryptic exon in GPSM2 mRNA amplified by conventional PCR (excised from gels shown in Figure S1 ). Figure S4 . The proposed RT-qPCR assay shows high efficiency, sensitivity and specificity for quantitative analyses of cryptic exons in ATG4B mRNA. By using this method total ATG4B mRNA (A) and cryptic exon in ATG4B mRNA (B) show similar values of efficiency and R 2 similar on standard curve and they show specific peaks in Melt Peak curves. Figure S5 . The proposed RT-qPCR assay shows high efficiency, sensitivity and specificity for quantitative analyses of cryptic exons in GPSM2 mRNA. By using this method total GPSM2 mRNA (A) and cryptic exon in GPSM2 mRNA (B) show similar values of efficiency and R 2 similar on standard curve and they show specific peaks in Melt Peak curves. Figure S6 . TARDBP regulates only ATG4B mRNA in vitro and positively correlates with ATG4B RNA expression in vivo. In vitro (A, B) , ATG4B downregulation induced by TARDBP knockdown (KD) in HeLa cells was not compensated by overexpression of other ATG4B homologs: ATG4A and ATG4C mRNA levels were quantified by RT-qPCR, both in basal conditions or after autophagy induction. ATG4D mRNA levels were not detected in HeLa cells using the indicated primers. Bars show mean values (± standard error) and a 2-way ANOVA analyses was performed (using a Bonferroni post hoc analyses). (C) In vivo expression analyses of TARDBP and ATG4B homologs show that there is a lineal relationship between TARDBP mRNA levels and ATG4B homologs (except ATG4D), though the highest slope was present in the TARDBP and ATG4B relationship. Levels of mRNAs for different tissues present in the graph were obtained from proteinatlas.org, using the HPA dataset (accessed December 2017). 
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